The genesis of an exceptionally lethal venom in the timber rattlesnake (Crotalus horridus) revealed through comparative venom-gland transcriptomics by Darin R Rokyta et al.
Rokyta et al. BMC Genomics 2013, 14:394
http://www.biomedcentral.com/1471-2164/14/394
RESEARCH ARTICLE Open Access
The genesis of an exceptionally lethal venom
in the timber rattlesnake (Crotalus horridus)
revealed through comparative venom-gland
transcriptomics
Darin R Rokyta*, Kenneth P Wray and Mark J Margres
Abstract
Background: Snake venoms generally show sequence and quantitative variation within and between species, but
some rattlesnakes have undergone exceptionally rapid, dramatic shifts in the composition, lethality, and
pharmacological effects of their venoms. Such shifts have occurred within species, most notably in Mojave (Crotalus
scutulatus), South American (C. durissus), and timber (C. horridus) rattlesnakes, resulting in some populations with
extremely potent, neurotoxic venoms without the hemorrhagic effects typical of rattlesnake bites.
Results: To better understand the evolutionary changes that resulted in the potent venom of a population of C.
horridus from northern Florida, we sequenced the venom-gland transcriptome of an animal from this population for
comparison with the previously described transcriptome of the eastern diamondback rattlesnake (C. adamanteus), a
congener with a more typical rattlesnake venom. Relative to the toxin transcription of C. adamanteus, which consisted
primarily of snake-venommetalloproteinases, C-type lectins, snake-venom serine proteinases, and myotoxin-A, the
toxin transcription of C. horridus was far simpler in composition and consisted almost entirely of snake-venom serine
proteinases, phospholipases A2, and bradykinin-potentiating and C-type natriuretic peptides. Crotalus horridus lacked
significant expression of the hemorrhagic snake-venommetalloproteinases and C-type lectins. Evolution of shared
toxin families involved differential expansion and loss of toxin clades within each species and pronounced differences
in the highly expressed toxin paralogs. Toxin genes showed significantly higher rates of nonsynonymous substitution
than nontoxin genes. The expression patterns of nontoxin genes were conserved between species, despite the vast
differences in toxin expression.
Conclusions: Our results represent the first complete, sequence-based comparison between the venoms of closely
related snake species and reveal in unprecedented detail the rapid evolution of snake venoms. We found that the
difference in venom properties resulted from major changes in expression levels of toxin gene families, differential
gene-family expansion and loss, changes in which paralogs within gene families were expressed at high levels, and
higher nonsynonymous substitution rates in the toxin genes relative to nontoxins. These massive alterations in the
genetics of the venom phenotype emphasize the evolutionary lability and flexibility of this ecologically critical trait.
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Background
Venomous snakes rely almost entirely on their complex,
largely proteinaceous venoms for feeding and defense,
resulting in strong selective pressures on the genes encod-
ing venom components [1-4] and on the ultimate repos-
itories of the venoms, the snakes’ prey [5] and predators
[6]. Although molecular signals of positive selection have
been repeatedly documented for individual venom com-
ponents through sequence comparisons across species
[1-4,7], such analyses characterize only minute portions
of the full evolutionary stories of venoms. Proteomic
approaches [8] can characterize full-venom patterns of
divergence between species [9,10], but only in broad
strokes, failing to differentiate members of large venom-
gene families and to provide information on sequence
divergence. Even the most complex venoms are sim-
ple in terms of the number of gene families or toxin
classes present; the hundreds of proteins [11] typi-
cally belong to less than 20 gene families. Proteomic
approaches therefore average out many of the details of
venom evolution. Venom-gland transcriptomics [12-16]
have the unrealized potential to combine many, but cer-
tainly not all, of the benefits of both approaches. With
adequate sequencing effort, transcriptomes can provide
the full-venom information of proteomics approaches
as well as the information-dense gene sequences for
molecular-evolutionary analyses [17], although post-
transcriptional regulation could lead to significant dis-
crepancies between venom content and expressed toxin
mRNAs [18].
Snake-venom composition can vary significantly
between species [18,19], within and between popula-
tions of a single species [18-25], and even ontogenetically
within an individual [10,26-30]. This variation is related,
at least in part, to differences in diets [31]. Some gen-
eral, recurrent patterns have been identified within this
extensive variation, including the type I/II rattlesnake-
venom classification described by Mackessy [29], which
emphasizes the inverse relationship between toxicity
and metalloproteinase activity seen in many rattlesnake
venoms. Snake-venom metalloproteinases (SVMPs) are
enzymes that break down components of the capillary
basement membrane, resulting in local and systemic
hemorrhage. SVMPs are more generally known to dis-
rupt hemostasis and cause inflammation and apoptosis
[32]. Type I venoms have high metalloproteinase activity
and high LD50 values (> 1.0 μg/g mouse body weight),
whereas type II venoms have low metalloproteinase activ-
ity and low LD50 values (< 1.0 μg/g mouse body weight).
High metalloproteinase activity and high toxicity appear
to be incompatible properties of rattlesnake venoms [33].
Type I venoms are by far the most prevalent of the two
venom types, appearing in 20 out of 26 rattlesnake taxa
examined by Mackessy [29]. Mackessy [29] also revealed
that different subspecies can have different venom
types. For example, the massasauga (Sistrurus catenatus)
expresses type I venom in some subspecies (S. c. tergemi-
nus) and type II in others (S. c. catenatus and perhaps S.
c. edwardsi). Other studies have shown ontogenetic shifts
between venom types, with juveniles expressing type II
venom but switching to type I as adults [34,35]. Some
species, such as C. durissus, are known to express type II
venom as both juveniles and adults, a pattern hypothe-
sized to represent paedomorphism [10]. Despite themajor
differences in pharmacology and composition between
these two venom types, evolutionary transitions between
them appear to be common and to occur in parallel in
several different species and perhaps even in different
populations of the same species, despite the relatively
short time (∼12.7 million years) since Crotalus diverged
from Sistrurus [36]. The selective pressures favoring these
transitions, the events triggering or enabling them, and
the precise nature of any expression or genetic changes
resulting in the altered venom properties are unknown.
The determination of these unknowns not only has impli-
cations for our understanding of the evolution of major
phenotypic innovations, but also has practical implica-
tions for snakebite treatment. Although type II venoms are
the minority, bites from snakes with type II venoms show
drastically different pathologies that might require unique
treatment approaches.
The eastern diamondback rattlesnake (C. adamanteus)
and the timber rattlesnake (C. horridus) are among the
largest rattlesnake species, capable of reaching lengths
of 2.4 m and 1.9 m, respectively [37]. Crotalus horridus
occurs from New England and extreme southern Ontario,
southward to northern Florida, and westward to eastern
Texas and extreme southeastern Minnesota [38]. Cro-
talus adamanteus is a species of the southeastern coastal
plain, ranging from extreme southeastern North Carolina,
southward to the Florida Keys, and westward along the
coast to extreme eastern Louisiana, and is also com-
mon on many of the Atlantic and Gulf barrier islands
[38]. The two species are sympatric in parts of the Car-
olinas, Georgia, northern Florida, Alabama, Mississippi,
and Louisiana, although they appear to be partitioned by
habitat preference. Crotalus adamanteus is more often
encountered in areas of high, dry, sandy soils, and C.
horridus is more often found in low, wet bottomlands
[37,39]. Both species are of conservation concern because
of habitat loss and human persecution [40-43]. Crotalus
horridus has been extirpated from many areas, particu-
larly in the northern part of its range, and is classified
as endangered in six states and threatened in five oth-
ers. Crotalus adamanteus is listed as endangered in North
Carolina and is currently being reviewed for federally
threatened status under the Endangered Species Act. The
diets of both species are similar, consisting primarily of
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rabbits, squirrels, rats, mice, and occasionally birds, with
rabbits being more commonly consumed by the larger C.
adamanteus [37].Crotalus horridus also occasionally con-
sumes frogs and snakes [37]. Despite their similarities in
size and diet, the venoms from some populations of the
two species show dramatic differences in pharmacological
properties, composition, and toxicity. Crotalus adaman-
teus and most populations of C. horridus express type I
venom [17,29], but at least two distinct, southern popula-
tions of C. horridus express venoms consistent with a type
II classification [44].
Straight andGlenn [45] isolated an extremely lethal, het-
erodimeric phospholipase A2 (PLA2) presynaptic neuro-
toxin from C. horridus, which was homologous to Mojave
toxin from C. scutulatus [46] and crotoxin from C. duris-
sus terrificus [47]. Related toxins have also been found in
C. helleri [48], C. tigris [49], neonates of C. simus [10], and
rattlesnakes in the genus Sistrurus [50]. The C. horridus
toxin was named canebrake toxin because it was discov-
ered from a northern-Florida specimen belonging to the
former subspecies C. h. atricaudatus, known colloqui-
ally as the canebrake rattlesnake. Glenn et al. [44] further
characterized this neurotoxin, examined its geographic
distribution, and found a complex pattern of venom com-
position in relation to the presence/absence of canebrake
toxin and hemorrhagic activity. Crotalus horridus indi-
viduals fall into one of four venom types: type A venoms
have canebrake toxin but no hemorrhagic activity, type
B venoms lack canebrake toxin but have hemorrhagic
activity, type A+B venoms have both canebrake toxin and
hemorrhagic activity, and type C venoms have neither
canebrake toxin nor hemorrhagic activity. Types A and B
appear to be the most common types, suggesting a strong
inverse relationship in venom composition between cane-
brake toxin and toxins such as SVMPs, which are major
contributors to tissue damage and hemorrhage. Type B
venom dominates throughout most of the range of C. hor-
ridus with only two known, disjunct regions where type
A is common, one of which (southeastern South Carolina
through eastern Georgia and northern Florida) falls in one
of the regions of sympatry with C. adamanteus. Type A
venom would be considered a type II rattlesnake venom
under Mackessy’s classification, whereas type B would be
a type I [29]. In terms of LD50 in mice, the order of
decreasing toxicity for these venom types is: A > A+B >
B > C. Analogous venom types, excluding type C, have
been identified in C. scutulatus [46] and C. helleri [48] in
relation to the presence or absence of Mojave toxin. These
venom types, in particular types A and B, reflect vastly dif-
ferent prey incapacitation strategies and possibly different
feeding ecologies, because types A and C lack predi-
gestive effects. Low hemorrhagic activity could limit the
maximum size of prey that can be consumed or prevent
effective digestion at suboptimal temperatures, thereby
inducing altitudinal, geographical, or seasonal limitations
on foraging [33].
The venom-gland transcriptome of C. adamanteus
from northern Florida has been extensively character-
ized by means of 454 pyrosequencing [4] and Illumina
sequencing [17], and this species’ venom is clearly type I
on the basis of its biochemical properties, LD50 [29], and
expressed venom genes [17]. The most abundant tran-
script in its venom gland encoded a myotoxin-A (i.e.,
crotamine; MYO), and SVMPs were the most abundant
toxin class [17]. To compare venom-gland expression pat-
terns between a rattlesnake with type I venom and one
with type II and to elucidate the evolutionary genesis of
these venom types, we sequenced the venom-gland tran-
scriptome of C. horridus from northern Florida by means
of Illumina technology, following the sequencing and de
novo assembly approach used for C. adamanteus [17]. We
provide the first comprehensive, sequence-based compar-
ison of venoms between two closely related snake species
and the first in-depth examination of toxin gene-family
evolution, expression, and reorganization resulting from
recent species divergence.We generated the first genome-
scale analysis of snake molecular evolution on the basis
of thousands of newly annotated nontoxins and com-
pared the evolution of toxin sequences to these nontoxin
sequences to determine whether toxins are unique in their
evolutionary patterns. While a comparison between the
venom-gland transcriptomes of the two venom types in C.
horridusmight have provided a more precise comparison
of expression patterns underlying the two venom types,
such a comparison would provide substantially less data
on toxin and nontoxin molecular evolution and on pat-
terns of gene-family evolution in snake venoms. By com-
paring the venom-gland transcriptomes of C. horridus
and C. adamanteus, we provide the first transcriptome-
based comparison between type I and type II rattlesnake
venoms and the first genome-scale characterization of
molecular divergence between two closely related ven-
omous snake species.
Results and discussion
Crotalus horridus venom-gland transcriptome sequencing
and assembly
We generated a total of 113,344,311 pairs of 100-nucle-
otide (nt) raw reads, and 104,457,593 pairs passed the
Illumina quality filter. We merged 64,169,665 pairs into
high-quality composite reads on the basis of their 3’ over-
laps as described by Rokyta et al. [17] and Rodrigue et al.
[51]. These composite reads had average lengths of 133 nt
with average phred scores of 46 and were the only reads
used for assembly. Although we could have simply aligned
our C. horridus sequencing reads to the transcripts pre-
viously identified for C. adamanteus, we performed an
independent de novo assembly to provide confirmation of
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theC. adamanteus annotations, increase the total number
of gene sequences identified for the genus Crotalus, and
avoid propagating any errors that might be present in the
C. adamanteus assembly.We followed the iterative assem-
bly approach of Rokyta et al. [17]. We began by running
the Extender program described by Rokyta et al. [17] on a
set of 1,000 random reads to identify any extremely high-
abundance transcripts. This procedure resulted in 670
contigs, 386 of which had full-length coding sequences.
After eliminating duplicates, we had 39 nontoxins and 27
toxins. The high number of duplicates was indicative of
extremely biased expression in the venom glands. With
these 66 transcripts, we filtered∼37% of the original reads
and performed a de novo assembly with NGen on 10
million of the unfiltered reads. This assembly produced
6,112 contigs from which we annotated 24 full-length
toxin and 1,479 full-length nontoxin transcripts. These
1,503 transcripts were used to filter ∼30% of the previ-
ously unfiltered reads, and 10 million of the remaining
reads were used in a second de novo NGen assembly.
This assembly produced 7,084 contigs, and we annotated
25 full-length toxin and 1,080 full-length nontoxin tran-
scripts from these contigs. These 1,105 transcripts were
used in a third and final filtering step, removing ∼12%
of the reads from the previous set, and 10 million of
the unfiltered reads were used in a final de novo NGen
assembly. Of the resulting 6,825 contigs, 16 were anno-
tated as full-length toxins and 580 as full-length nontox-
ins. After eliminating duplicates, our procedure generated
3,031 unique, full-length nontoxin coding sequences and
61 unique, full-length putative-toxin coding sequences.
Our 3,031 full-length, annotated nontoxin sequences
accounted for 24.8% of the total sequencing reads, and
our 61 toxin transcripts accounted for an additional 40.9%,
illustrating clearly the extreme specialization of the venom
gland. We were able to account for 65.7% of the sequenc-
ing reads (Figure 1). These percentages were similar to
those of Rokyta et al. [17] who used the same overall
sequencing and assembly approach for C. adamanteus
(Figure 1). Our 3,092 annotated sequences (and the 3,002
sequences annotated for C. adamanteus by Rokyta et al.
[17]) represent substantial fractions of the genes encoded
by these rattlesnakes’ genomes; for comparison, 17,472
protein-coding genes were annotated from a full-genome
assembly of the green anole lizard Anolis carolinensis
[52]. The sequences generated in the present work and by
Rokyta et al. [17] should facilitate genome sequencing and
annotation for viperid snakes.
In all that follows, we used the percentage of reads map-
ping to a given transcript as a proxy for its expression
level. This approach was used by Rokyta et al. [17] for
C. adamanteus, against whose results we will be mak-
ing extensive comparisons, and matches the measures
used in the many Sanger-sequencing-based venom-gland
transcriptomic studies for snakes [13,14,53-62]. A mea-
sure such as average coverage might help correct for any
correlation between the number of reads mapping to a
transcript and its length, but our data showed no signif-
icant relationship between these two values (F1,3082 =
0.60, P = 0.44). The measures of reads per kilobase of
exon model per million mapped reads (RPKM) [63,64] or
fragments per kilobase of transcript per million mapped
reads (FPKM) for paired-end reads [65] offer normaliza-
tion for coding-RNA length and the total number of reads,
providing an analog of the relative molar concentrations
of transcripts. Note that our sequences, being processed
mRNAs, lack introns, and this normalization for cod-
ing length is therefore less critical. More sophisticated
normalization approaches have also been described [66]
for RNA-seq data, but the optimal measure of transcript
abundance remains under debate [67] and depends on the
purpose and nature of the analyses. Generally, we were
concerned with how transcriptional effort is apportioned
among transcripts, which makes percentages a natural
measure. In addition, percentages yield a form of com-
positional data [68], which has well-studied properties
that enable natural comparisons among subsets. Such an
approach is natural for gene-expression data [69].
Type II Crotalus horridus toxin-gene expression patterns
Some of the 61 toxin sequences were similar enough to
potentially confound estimates of their individual abun-
dances, so for the purpose of estimating transcript abun-
dances, we clustered these sequences whenever they
showed less than 1% nt divergence in their coding
sequences. The clustering threshold of 1% is arbitrary but
matches the approach used by Rokyta et al. [17] for C.
adamanteus. Our average composite-read lengths of 133
nt and a minimum nt divergence of 1% ensure that reads
can generally be mapped uniquely to contigs. Cluster-
ing the original 61 toxin sequences resulted in 53 toxin
clusters (Table 1). In all clusters, the mutations respon-
sible for the differences between the sequences were at
substantial frequencies (>10%) with high coverage, sug-
gesting that these sequences were either alleles or recent
duplicates rather than simply sequencing errors. Toxins
were named by a toxin-class abbreviation, a number des-
ignating the cluster (if multiple clusters were present for
the class), and a lower-case letter (if the cluster included
more than a single sequence). Where necessary to differ-
entiate between species, we preceded toxin names with
“Cadam” to indicate those sequences identified in the C.
adamanteus transcriptome and “Chorr” to indicate those
sequences identified in the C. horridus transcriptome.
Toxin sequences were vastly overrepresented in the
venom-gland transcriptome of C. horridus (Figure 2),
accounting for 40.9% of the total reads (Figure 1). The
seven most highly expressed genes were toxins, as were 15
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C. horridus C. adamanteus
Figure 1 The venom compositions of Crotalus adamanteus and C. horridus differed drastically, consistent with their respective type I and
type II classifications. The toxin-gene expression of C. adamanteus was dominated by snake-venommetalloproteinases (SVMPs), C-type lectins
(CTLs), snake-venom serine proteinases (SVSPs), and a single, high-abundance myotoxin-A (MYO). These toxin classes, with the exception of SVSPs,
were barely detectable in the venom-gland transcriptome of C. horridus, despite a similar number of reads mapping to toxins. The venom-gene
expression of C. horridus was instead dominated by SVSPs, phospholipases A2 (PLA2s), and a single gene encoding bradykinin-potentiating and
C-type natriuretic peptides (BPP). For both species, unique toxin sequences were grouped into clusters showing less than 1% nucleotide
divergence. The other toxin-class abbreviations are as follows: cysteine-rich secretory protein, CRISP; and L-amino acid oxidase, LAAO.
of the 20 most highly expressed genes. Of the 200 most
highly expressed genes, 34 were toxins (Figure 2A). As
has been noted previously for other species [4,17,60], the
venom gland of C. horridus is highly specialized for the
production of toxic proteins.
The venom of C. horridus, in terms of gene expression,
was dominated by three classes of toxin: snake-venom
serine proteinases (SVSPs), PLA2s, and bradykinin-
potentiating and C-type natriuretic peptides (BPP;
Figure 1 and Table 1). These three toxin classes accounted
for 93.5% of the reads mapping to toxin sequences. The
11 clusters of SVSPs accounted for 58.2% of the toxin-
encoding reads. These enzymatic venom components
show highly variable substrate specificities but generally
catalyze reactions that disrupt hemostatic mechanisms,
including the coagulation cascade and the kallikrein-
kinin, fibrinolytic, and complement systems [13,70]. The
nine clusters of PLA2s accounted for 22.8% of the toxin
reads. PLA2s show an astounding array of toxic functions,
including neurotoxic, cardiotoxic, myotoxic, hemolytic,
convulsive, anticoagulant, antiplatelet, edema-inducing,
and tissue-damaging effects [71,72]. Crotalus horridus
from the geographic region from which our animal was
collected are known to express an extremely potent,
heterodimeric, presynaptic β-neurotoxin known as cane-
brake toxin [44,45,73], which is homologous to the noto-
riously lethal Mojave toxin of C. scutulatus and crotoxin
of C. durissus terrificus. These toxins comprise two non-
covalently associated subunits, both of which are derived
from PLA2 paralogs. The basic subunit is weakly toxic
on its own and shows PLA2 activity. The acidic subunit
is nontoxic alone and consists of three disulfide-linked
polypeptide chains proteolytically derived from a PLA2-
like precursor. The two most abundant PLA2 transcripts
in the C. horridus venom-gland transcriptome, PLA2-2
and PLA2-1a, are most likely the basic and acidic chains
of the canebrake toxin and account together for 15.2%
of the toxin reads (Figure 2 and Table 1). PLA2-2 is
2.2% divergent at the nt level and 3.7% divergent at the
amino-acid level from the crotoxin basic subunit (Gen-
Bank accession X12603). PLA2-1a is 3.2% divergent at the
nt level and 8.4% divergent at the amino-acid level from
the crotoxin acidic subunit (GenBank accession X12606).
Crotalus horridus actually appeared to express four paral-
ogous versions of the acidic subunit, including PLA2-1a,
PLA2-4, PLA2-6, and PLA2-9 (Figure 3). The single BPP
cluster in the C. horridus venom gland accounts for 12.5%
of the toxin reads. These toxins are noted for lower-
ing blood pressure in bite victims [13]. Together, these
three major classes of toxins in high abundance suggest a
unique viperid bite pathology consisting of coagulopathic,
hypotensive, and neurotoxic effects.
Major classes typical of viperid venoms are notably
at extremely low abundances in the C. horridus venom
(Figure 1 and Table 1). We detected only three clusters of
SVMPs, which accounted for just 0.11% of the toxin reads.
These venom enzymes are responsible for most of the tis-
sue damage and hemorrhage associated with most viperid
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Table 1 Expression levels of full-length toxin clusters for Crotalus horridus
Rank Cluster name Cluster size Length % total reads % toxin reads
1 SVSP-1a 2 3,346 6.762 16.534
2 SVSP-3a 2 1,915 6.272 15.337
3 BPP-1a 2 1,484 5.120 12.519
4 SVSP-10 1 2,512 4.131 10.101
5 PLA2-2 1 880 3.346 8.183
6 SVSP-2a 2 2,089 3.305 8.082
7 PLA2-1a 2 933 2.884 7.051
8 PLA2-3 1 832 1.349 3.298
9 SVSP-7 1 2,209 0.900 2.200
10 SVSP-4a 2 2,354 0.827 2.021
11 VEGF-1 1 1,352 0.797 1.948
12 PLA2-4 1 1,303 0.687 1.681
13 PLA2-6 1 880 0.542 1.325
14 PLA2-9 1 812 0.502 1.228
15 SVSP-5 1 2,968 0.466 1.140
16 LAAO 1 2,890 0.452 1.106
17 SVSP-8 1 1,718 0.438 1.071
18 SVSP-11 1 2,704 0.384 0.940
19 CRISP 1 6,054 0.317 0.775
20 VESP 1 1,587 0.262 0.640
21 SVSP-9 1 1,341 0.189 0.461
22 SVSP-6 1 1,794 0.140 0.342
23 NGF 1 1,074 0.114 0.280
24 NUC 1 2,538 0.114 0.278
25 PDE 1 2,790 0.106 0.260
26 NF 1 1,230 0.088 0.215
27 MYO 1 415 0.080 0.195
28 VEGF-2 1 5,612 0.044 0.107
29 SVMPIII-1 1 3,395 0.040 0.099
30 KUN-1 1 2,246 0.040 0.099
31 HYAL 1 3,477 0.038 0.093
32 CTL-10 1 633 0.029 0.070
33 CREGF 1 1,625 0.028 0.069
34 GC 1 6,138 0.021 0.051
35 CTL-11 1 575 0.019 0.046
36 CTL-2a 2 669 0.011 0.027
37 KUN-2 1 4,317 0.008 0.020
38 CTL-1a 2 815 0.006 0.015
39 CTL-3 1 735 0.006 0.015
40 CTL-8 1 808 0.006 0.015
41 CTL-7 1 644 0.005 0.012
42 SVMPI 1 1,677 0.004 0.009
43 PDE-6 1 4,011 0.004 0.009
44 PDE-4 1 3,553 0.003 0.006
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Table 1 Expression levels of full-length toxin clusters for Crotalus horridus (Continued)
45 VF 1 5,139 0.002 0.005
46 CTL-4 1 697 0.002 0.004
47 CTL-5 1 743 0.002 0.004
48 PLA2-5 1 612 0.001 0.003
49 CTL-9 1 803 0.001 0.003
50 SVMPIII-2 1 2,499 0.001 0.003
51 CTL-6 1 637 0.001 0.002
52 PLA2-8 1 547 0.001 0.002
53 PLA2-7 1 546 0.001 0.001
bites [74] and contribute to predigestion of prey [33]. Sim-
ilarly, the 11 C-type lectin (CTL) clusters accounted for
just 0.22% of the toxin reads. These toxins, which typically
function as multimers, are major components of hemor-
rhagic viperid venoms and contribute to the disruption
of hemostasis by affecting plasma components and blood
cells [75], ultimately leading to hemorrhage [76]. Finally, a
single MYO cluster was detected, but it accounted for just
0.20% of the toxin reads. Although MYOs appear to be
compatible with both type I and type II venoms [33], their
primary role appears to be rapid prey incapacitation. A
highly potent neurotoxin like canebrake toxin may render
this particular toxin unnecessary.
We detected a number of additional low-abundance
toxins in the venom-gland transcriptome of C. horridus
(Figures 1 and 2 and Table 1). We identified an L-
amino acid oxidase (LAAO) transcript, accounting for
1.11% of the toxin reads. LAAOs are associated with
edema, apoptosis, and the inhibition of platelet aggrega-
tion [77]. A single cysteine-rich secretory protein (CRISP)
sequence accounted for 0.78% of the toxin reads. CRISPs
are thought to interfere with smooth-muscle contrac-
tion [78,79]. The remaining 15 putative toxin sequences
accounted for 4.08% of the toxin reads and included two
vascular endothelial growth factors (VEGFs), a vespryn
(VESP) [80,81], a nerve growth factor (NGF), a nucleoti-
dase (NUC), three phosphodiesterases (PDEs), a neu-
rotrophic factor (NF), two Kunitz-type protease inhibitors
(KUNs), a hyaluronidase (HYAL) [82], a cysteine-rich
with EGF-like domain protein (CREGF), a glutaminyl-
peptide cyclotransferase (GC) [83], and a venom factor
(VF) [84,85].
Type I versus type II: mRNA expression differences underlie
rapid phenotypic evolution
The profiles of toxin classes expressed by type II C.
horridus and its type I congener C. adamanteus were
vastly different but consistent with their classifications
as type I and type II venoms (Figure 1). These dras-
tic differences were present despite the similarities in
sizes, diets, and natural history of these two species
and the similarity in the relative transcriptional effort
expended on venom production (Figure 1). Type II ven-
oms tend to be proteomically simpler than type I [49], and
the transcriptome profiles that underlie these two ven-
oms followed this trend. Crotalus adamanteus had 123
unique toxin sequences that fell into 78 clusters. Cro-
talus horridus had just 61 unique toxin sequences in 53
clusters. In terms of unique venom transcripts or toxin
clusters, C. horridus had approximately 50 to 66% the
complexity of C. adamanteus. In terms of major toxin
classes, the simplicity of C. horridus venom was even
more apparent. SVSPs, PLA2s, and, to a lesser extent,
BPP made up most of the C. horridus venom tran-
scripts (93.5% of the toxin reads), whereas the venom
of C. adamanteus had a more even expression distribu-
tion over SVMPs, CTLs, SVSPs, MYO, PLA2s, and LAAO
transcripts (Figure 1).
The prevalence of the more complex type I venoms in
rattlesnakes [29] is difficult to reconcile with the advan-
tages type II venoms appear to confer. The higher lethality
of type II venoms implies greater efficacy in prey cap-
ture and reduced energetic costs, although toxicity has
not been measured in natural, sympatric prey popula-
tions. Complex traits have been hypothesized to pay a
cost in terms of their rates of adaptation [86], but this
result depends on high levels of pleiotropy that do not
appear to hold in most natural systems [87]. On the
other hand, the higher complexity of type I venoms could
lead to higher survival probability by means of functional
redundancy, mutational robustness, and even increased
rates of adaptation through an enlarged mutational tar-
get [88]. These potential advantages for type I venoms
would provide more of a long-term evolutionary advan-
tage, whereas the increased toxicity of type II venoms
provide an immediate short-term fitness advantage. This
hypothesized conflict between short-term and long-term
advantages might explain both the overall prevalence of
type I venoms among rattlesnakes and the fact that most
species with type II venoms are still polymorphic for
type I, even though type II venom dominates certain
geographic regions.


























































































































































Figure 2 The venom-gland transcriptome of Crotalus horriduswas dominated by toxin transcripts. The 61 unique toxin transcripts were
grouped into 53 clusters with less than 1% nucleotide divergence for this analysis. Note that all vertical axes are on log scales. (A) The overall
expression patterns with all of the full-length annotated sequences showed that toxins dominated the high-abundance transcripts. The inset shows
a magnification of the 200 most-abundant transcripts. (B) Expression levels of the toxin sequences showed a clear dominance of snake-venom
serine proteinases (SVSPs), phospholipases A2 (PLA2s), and a single gene encoding bradykinin-potentiating and C-type natriuretic peptides (BPP).
Expression levels among members of toxin classes were highly variable. The remaining toxin-class abbreviations are as follows: C-type lectin, CTL;
cysteine-rich secretory protein, CRISP; cysteine-rich with EGF-like domain, CREGF; glutaminyl-peptide cyclotransferase, GC; hyaluronidase, HYAL;
Kunitz-type protease inhibitor, KUN; L-amino acid oxidase, LAAO; myotoxin-A, MYO; nerve growth factor, NGF; neurotrophic factor, NF; nucleotidase,
NUC; phosphodiesterase, PDE; snake-venommetalloproteinase, SVMP; vascular endothelial growth factor, VEGF; venom factor, VF; and vespryn, VESP.


































Figure 3 Different clades were diversified and highly expressed in Crotalus adamanteus and C. horridus for the phospholipase A2 (PLA2)
gene family. The bars adjacent to gene names give expression levels relative to the most highly expressed family member by species. A completely
colored bar indicates the highest expression for the species. Clades comprising sequences from a single species either represent gene-family
expansion for that species or gene-family contraction for the other. The four-gene clade including Chorr PLA2-1a and the five-gene clade including
Cadam PLA2-1a are clear examples of this phenomenon. Duplication and gene-loss events were inferred by means of a duplication-loss parsimony
model. We used a homologous nontoxin-PLA2 sequence from the european rabbit (Oryctolagus cuniculus) as an outgroup to root the phylogeny.
Bayesian posterior probabilities are shown for clades for which the values exceeded 50%. Numbers within circles indicate that more than one
duplication event was inferred for that node.
Type II venoms are defined in part by their lack of
hemorrhagic effects and, in particular, low SVMP activ-
ity. For the type I venom of C. adamanteus, SVMPs
were the most highly expressed toxin class, accounting for
24.4% of the reads mapping to toxins. In stark contrast,
SVMPs were almost undetectable in the expressed genes
of the C. horridus venom-gland transcriptome, account-
ing for just 0.11% of the toxin reads (Figure 1). CTLs
contribute to hemorrhage by either inhibiting or activat-
ing, and thereby depleting, coagulation factors [76]. They
account for 22.2% of the toxin reads for C. adaman-
teus but just 0.2% of the toxin reads for C. horridus
(Figure 1). The lack of hemorrhagic activity by C. hor-
ridus venom can therefore be explained by the lack of
expression of genes responsible for this activity; we do
not yet know whether all of these genes are still present
in the genome but no longer expressed, or whether they
have been lost from the genome. We do know, how-
ever, that some are present but expressed only in minute
amounts (Figures 1 and 2).
Type II venoms are characterized by significant neuro-
toxic effects mediated generally by heterodimeric PLA2s
homologous to crotoxin. The crotoxin homolog in C. hor-
ridus, canebrake toxin, is responsible for most of the tox-
icity of the type A venoms [44], and also accounts in part
for the difference in PLA2 expression levels between C.
adamanteus andC. horridus (Figure 1).Crotalus adaman-
teus expressed modest amounts of PLA2 transcripts (7.8%
of its toxin reads), but, for C. horridus, PLA2s were the
second most abundant class (22.8% of toxin reads). In
C. scutulatus, which shows similar venom types to C.
horridus, populations with predominantly type II venom
show a corresponding absence of MYO [25], which causes
myonecrosis and spastic hind-leg paralysis. The most
abundantly expressed gene in the C. adamanteus venom-
gland transcriptome was a MYO related to crotamine, but
this gene was barely detectable in our type II C. horridus,
accounting for just 0.2% of the toxin reads. This toxin’s
probable role, prey incapacitation, is probably subsumed
by the action of canebrake toxin in C. horridus.
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Both species expressed high levels of SVSP transcripts,
although SVSP transcripts accounted for a significantly
larger portion of the toxin expression in C. horridus
than in C. adamanteus (58.2% versus 20.0% of the toxin
reads). Interestingly, the acidic subunit of crotoxin and its
homologs are proteolytically cleaved into three peptides
to produce the mature toxin; the protease responsible for
the reaction is unknown, but could potentially be one
or more serine proteinases, which might account for the
higher expression of SVSPs in C. horridus.
A full proteomic characterization [8] and comparison
will be necessary to determine whether the expression dif-
ferences described above account for all of the differences
in composition between the venoms of C. adamanteus
and C. horridus. We have shown that dramatic changes in
expression patterns for toxin gene classes underlie the cor-
respondingly dramatic differences in venom composition
and can account for the major pharmacological differ-
ences in the effects of the two venoms. In addition to the
expression changes by toxin classes, changes of expres-
sion among paralogs within classes and sequence changes
in individual toxins could also contribute to the differ-
ent properties of the venoms (see below). Nonetheless, we
have shown that extremely large and evolutionarily signif-
icant phenotypic changes between closely related species
can bemediated by major changes in gene-expression pat-
terns involving many genes, even over short evolutionary
times. These dramatic changes in expression highlight a
major advantage of chemical means of prey incapacitation
and defense. Because venom genes, as far as is known, are
expressed only in the venom glands (but see Casewell et al.
[89]), major alterations in venom-gene expression can be
achieved with no antagonistic pleiotropic effects. Similar
large expression shifts for more typical genes would prob-
ably be strongly deleterious. Venoms are clean phenotypic
modules that can undergo large changes with few, if any,
deleterious pleiotropic effects, giving them potential for
high evolvability.
Type II venoms differ extensively among species
Although type II venoms are unified in their broad phar-
macological properties, they are far from uniform in their
compositions. In those cases where it has been investi-
gated, the neurotoxicity of these venoms was derived from
the heterodimeric PLA2 crotoxin and its homologs, but
the few data available suggest differences in the remain-
der of the expressed genes as well as in the relative
amount of crotoxin homologs. A low-coverage venom-
gland transcriptome for C. durissus collilineatus [60],
which expresses type II venom, showed that the tran-
scripts encoding the two subunits of crotoxin account
for 88% of the toxin-encoding transcripts. In contrast,
PLA2 transcripts as a class only accounted for 22.8% of
the toxin reads for C. horridus. SVSP transcripts were
the most abundant toxin class for C. horridus at 58.2% of
the toxin reads, but they only accounted for 2.5% of the
toxin sequences for C. durissus collilineatus. Proteomic
data from C. simus neonates [10] and C. tigris [49], both of
which express type II venoms, suggest a closer agreement
with our results. In both cases, however, the SVSPs were
expressed at lower levels than for C. horridus (36.0% and
26.8% compared to 58.2%), and the PLA2s were expressed
at higher levels (55.9% and 66.2% compared to 22.8%).
Note, however, that we are comparing transcriptomes to
proteomes, which do not always show quantitative agree-
ment [90]. Nonetheless, these differences may be respon-
sible for the lower LD50 for the venom of C. tigris (0.07
μg/g) compared to type II C. horridus (0.22–1.0 μg/g)
[29,44].
If we assume that type I venom in adults is ancestral
on the basis of its higher frequency among extant species
[29], then the transition to type II venomhas occuredmul-
tiple times in rattlesnakes within the last ∼12.7 million
years [36], a remarkable example of parallel phenotypic
evolution. Calvete et al. [10] suggested that for C. duris-
sus, type II venom represents a paedomorphic trait. If the
ancestral state of rattlesnakes involved a switch between
type II venom in neonates to type I as adults, such as
is currently seen in C. simus [10], paedomorphism could
provide a simple mechanism for frequent parallel evolu-
tion [33]. Unfortunately, the frequency of type II to type
I ontogenetic shifts in rattlesnakes is unknown, although
ontogenetic shifts in venom composition are not uncom-
mon in viperids [10,26-28,91-93]. Of course, given the
well-known among-species variation in venom composi-
tion of adult snakes, we expect similar levels of varia-
tion among juvenile venoms, thereby compounding the
difficulties in elucidating the evolutionary history and
patterns for snake venoms. A full investigation into the
mechanisms of evolution of type II venom phenotypes in
rattlesnakes, including determination of whether they rep-
resent paedomorphic traits, could provide insight into the
repeatability of and constraints on large-scale phenotypic
evolution.
Toxin gene-family expansion and differential paralog
expression
The evolution of animal-toxin multigene families is char-
acterized by frequent gene gain and loss and strong
positive selective pressures [1]. Such patterns have been
described for PLA2s [2] and three-finger toxins [7] in
snakes. Unfortunately, studies of these gene families rely
on sparse and unsystematic sampling of toxin sequences
within species and uneven sampling across species [7]
because, until recently [4,17], complete, sequence-based
characterizations of the venom components of a species
were not feasible. Such sampling deficiencies probably
introduce little, if any, bias into statistical tests of positive
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selection, but could have substantial impacts on the esti-
mation of duplication and gene-loss rates. In particular,
this bias could generate spurious signals for gene loss
[7]. With our two high-coverage venom-gland transcrip-
tomes for C. horridus and C. adamanteus, we provided
the first detailed characterization of toxin gene-family
evolution for snakes. Note that we could only detect
sequences present in the genome and expressed in the
venom glands, so gene loss in this context means that the
gene was either deleted from the genome or it was no
longer expressed. We only considered the evolution of the
PLA2s and SVSPs, because these two families were the
only two diverse gene families expressed at appreciable
levels in both species.
We identified nine PLA2 transcripts for C. horridus
and six for C. adamanteus (Figure 3) and used a related
sequence from the european rabbit (Oryctolagus cunicu-
lus) as our outgroup. This outgroup sequence was selected
on the basis of tblastx searches of our PLA2 sequences
against the NCBI nonredundant nt database, exclud-
ing results from viperids. To reconcile the PLA2 gene-
family tree with the known species tree required at least
13 duplication events, one loss in C. horridus, and 4
losses in C. adamanteus (Figure 3). Crotalus adaman-
teus lacked orthologs for the two most highly expressed
PLA2 paralogs for C. horridus: Chorr PLA2-1a and
Chorr PLA2-2. Both species had bursts of species-specific
gene-family expansion that involved multiple duplication
events (Figure 3). The most highly expressed PLA2 for C.
adamanteus, Cadam PLA2-1a, was part of a five-sequence
clade unique toC. adamanteus. Similarly, the secondmost
highly expressed PLA2 for C. horridus, Chorr PLA2-1a,
was part of a four-sequence clade unique to C. hor-
ridus. These results suggest that gene-family expansion
and expression levels are related, although this apparent
relationship could simply reflect the use of expansion as
a means of increasing expression levels. We identified 11
and 14 SVSP transcripts for C. horridus and C. adaman-
teus, respectively (Figure 4). The phylogeny of these
sequences, with an elapid SVSP as an outgroup, showed a
complex pattern of gene gain and loss, with an estimated
17 duplication events, three losses in C. horridus, and two
losses in C. adamanteus (Figure 4). In constrast to the
PLA2s, SVSPs showed no massive species-specific clade
expansions, although species-specific duplication events
were common (Figure 4). Similarly to the PLA2s, the SVSP
clades expressed at high levels were different between
the two species. For example, the most highly expressed
SVSP for C. horridus, Chorr SVSP-1a, was paired with
a low-expression C. adamanteus ortholog, Cadam SVSP-
2. Our results provided the first detailed characteriza-
tion of toxin gene-family evolution across closely related
species. We found an overall pattern of gene-family
expansion, with duplications greatly outnumbering losses.
At the full-venom level, transcriptional effort among toxin
classes was found to be dramatically different between C.
horridus and C. adamanteus (Figure 1), and this same pat-
tern repeated itself at a finer scale among paralogs within
toxin classes (Figures 3 and 4). Even over the short time
scale of divergence between congeners, expression levels
for toxins were highly dynamic.
Sequence divergence between Crotalus adamanteus and C.
horridus
Claims abound of increased and exceptional evolution-
ary rates and selective pressures affecting snake venom
genes [1-4], but these studies suffer from major limita-
tions. With the exception of Gibbs and Rossiter [3], these
studies average rates over the history of gene families
and species and therefore capture only long-term patterns
of molecular evolution. The most significant problem
with these studies is the complete lack of a null expec-
tation for molecular evolutionary patterns in snakes. We
would like to know the proportion of venom genes that
are evolving quickly over short time scales and whether
these genes, and by implication the venom trait itself, are
unique within the genome in terms of their evolutionary
patterns. To address these questions, we used our anno-
tated nontoxin sequences from C. adamanteus and C.
horridus as the basis for our null expectation for molec-
ular evolution and compared the patterns for toxins to
the patterns for nontoxins. To generate our null expec-
tations, we identified orthologous pairs of nontoxins for
the two species by means of reciprocal-blast analyses. We
excluded mitochondrially encoded sequences from these
analyses because of their well-known high evolutionary
rates. Each sequence for each species was searched against
a database generated for the other species, and we per-
formed separate searches on amino-acid sequences with
blastp and nucleotide sequences with blastn.We only kept
pairs of putative orthologs that were each others’ best
matches for both analyses. From the 3,021 sequences from
C. horridus and the 2,870 from C. adamanteus, we iden-
tified 1,903 putatively orthologous pairs. We excluded 90
pairs after alignment because their alignments contained
more than 24 gapped positions, leaving 1,813 aligned pairs
of orthologs. A similar treatment with the 79 toxin clus-
ters from C. adamanteus and 53 from C. horridus yielded
30 toxin alignments.
We conducted three separate analyses of molecular evo-
lution. For the first (Figure 5), we compared the pairwise
nonsynonymous to synonymous substitution-rate ratios
(dN/dS) of the toxins to the nontoxins. Because our
species were closely related and an accurate estimate of
dN/dS requires sufficient synonymous divergence, we
first estimated pairwise dS values and excluded pairs from
the analysis if dS < 0.001. In addition, we excluded pairs
for which dS > 0.1 to avoid spurious orthologs. These





















































Figure 4 The evolution of the snake-venom serine proteinase (SVSP) gene family in Crotalus adamanteus and C. horriduswas
characterized by duplication and changes in expression patterns. The bars adjacent to gene names give expression levels relative to the most
highly expressed family member by species. A completely colored bar indicates the highest expression for the species. Gene-family expansion and
contraction appear to be less pronounced in SVSPs than phospholipases A2 (Figure 3). Duplication and gene-loss events were inferred by means of
a duplication-loss parsimony model. We used a homologous SVSP from the king cobra (Ophiophagus hannah) as an outgroup to root the
phylogeny. Bayesian posterior probabilities are shown for clades for which the values exceeded 50%.
constraints left 1,644 nontoxin pairs and 29 toxin pairs.
The average dN/dS for nontoxins was 0.18, and the aver-
age for toxins was significantly higher at 0.63 (P  0.001
with a Wilcoxon rank sum test). As a class, toxins have a
higher dN/dS than the background nontoxins. We used
the individual values from the nontoxins to generate a
null distribution for genomic pairwise dN/dS and com-
pared our toxin values to this null distribution (Figure 5).
Nine of 29 toxin pairs exceeded the 95th percentile of
the null distribution, but we expected fewer than two
exceedances if the distributions were the same. About 30%
of toxin pairs have exceptionally high dN/dS ratios. As a
class of sequences and at the individual level, toxins are
distinct from nontoxins in terms of their dN/dS ratios.
The low level of sequence divergence between our two
species suggests that estimation of the dN/dS ratio may
be inaccurate, so we conducted two additional analyses
that were free of the issues of estimating a ratio where the
denominator is expected to be quite small. We estimated
null distributions of dS and dN separately for comparison
with the corresponding values from the toxins (Figures 6
and 7). If toxins are uniquely under positive selection,
we would expect to see higher rates of substitution for
nonsynonymous mutations, but we have no reason to
expect a corresponding increase in synonymous substi-
tution rates. Synonymous substitution rate can therefore
serve as a control. For both analyses, we excluded pairs
with dS > 0.1 as for our dN/dS analysis. For dN , we found
that the average value for toxins was 0.029, which was
significantly higher than the value of 0.017 for nontoxins
(P  0.001 with a Wilcoxon rank sum test). A majority of
toxin pairs (18 of 30) exceeded the 95% threshold estab-
lished by the nontoxin comparisons (Figure 7). However,
we also found that toxins had a higher dS than nontoxins









































































































































































Mean nontoxin dN/dS = 0.179









Figure 5 The distribution of pairwise dN/dS ratios for toxins compared to nontoxins. The histogram shows the null distribution of dN/dS for
pairs of nontoxin orthologs identified by means of a reciprocal blast search. The vertical line denotes the cutoff for the 95th percentile for the
nontoxins. The dN/dS values for the toxins are plotted below the histogram, and those toxin comparisons with values exceeding the 95th percentile
for nontoxins are indictated with triangles and labeled with the names of the two sequences compared. We only expected 1.45 toxins to exceed
this threshold if the distributions were the same for toxins and nontoxins. The P value is based on a Wilcoxon rank sum test and shows that the
average dN/dS is significantly different between toxins and nontoxins. Comparisons with dS > 0.1 were excluded. We also excluded comparisons
with dS < 0.001 to avoid inaccurately large dN/dS estimates.
(P < 0.001 with a Wilcoxon rank sum test), and seven of
30 toxin pairs exceeded the nontoxin 95% threshold. Six of
these seven pairs consisted of CTLs, which were expressed
at extremely low levels in the C. horridus transcriptome.
These pairs possibly represent incorrectly paired paralogs
that resulted from the low CTL coverage for C. horridus.
Excluding these exceptional seven from the dN analysis
still left 11 of 23 toxin pairs exceeding the dN thresh-
old established by the nontoxins. As expected for two
closely related species, the distributions of pairwise dN
(Figure 7) and dS (Figure 6) showed peaks at zero, corre-
sponding to pairs with little to no sequence divergence.
The distribution for dS had a second mode corresponding
to approximately 1% sequence divergence.
We have shown that even over the short amount of
time since C. horridus and C. adamanteus shared a com-
mon ancestor, many, but by nomeans all, venom-encoding
genes have evolved in an exceptional manner compared
to other coding sequences in the genome. About 30%
of toxin sequences showed evidence for a higher dN/dS
ratio relative to the nontoxin background sequences, a
pattern consistent with those sequences having experi-
enced stronger and/or more prolonged positive selection.
Only about 20% of toxins, however, showed dN/dS > 1
(Figure 5), which is definitive and extremely conserva-
tive [94] evidence for positive selection as opposed to
relaxed purifying selection. We also showed that about
50% of toxin sequences had exceptionally high nonsyn-
onymous substitution rates relative to nontoxins, which
is also consistent with strong, continual positive selec-
tion acting on toxins, although relaxed purifying selection
cannot be ruled out. Our null distributions for these
measures were derived from evolutionary patterns for a
diverse array of nontoxin sequences that were expressed
in the venom glands of both species and therefore may
not reflect the prevailing patterns throughout the rest
of the genome. Our large sample size of nearly 2,000
nontoxin genes, however, represents a substantial frac-
tion of the coding sequences in the genome. In addition,
the extremely different venom compositions of our two
species resulted in a fairly small sample size for toxins.
While this small sample size was sufficient to demonstrate
the molecular-evolutionary distinctiveness of toxins com-
pared to nontoxins, future comparisons among species
with the same venom types will provide more power and
higher-resolution characterizations of the differences in
evolutionary patterns between toxins and nontoxins.
Conserved nontoxin-expression patterns between Crotalus
adamanteus and C. horridus
The differences in expression patterns between C.
adamanteus and C. horridus for genes encoding putative
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Mean nontoxin dS = 0.017











Figure 6 The distribution of pairwise synonymous divergence (dS) for toxins compared to nontoxins. The histogram shows the null
distribution of dS for pairs of nontoxin orthologs identified by means of a reciprocal blast search. The vertical line denotes the cutoff for the 95th
percentile for the nontoxins. The dS values for the toxins are plotted below the histogram, and those toxin comparisons with values exceeding the
95th percentile for nontoxins are indictated with triangles and labeled with the names of the two sequences compared. The P value is based on a
Wilcoxon rank sum test and shows a significant difference between the average dS of toxins and nontoxins. Comparisons with dS > 0.1 were
excluded from the analysis. If the distributions were the same between toxins and nontoxins, we expected to see 1.5 toxins exceeding the threshold
instead of the seven that were observed. Six of these seven toxin pairs were C-type lectins, a toxin class that showed a 100-fold reduction in
expression in C. horridus relative to C. adamanteus. The CTLs above the threshold may represent a failure to find the true ortholog in the C. horridus
transcriptome due to low coverage.
toxins are dramatic (Figure 1) and commensurate with
the phenotypic difference in their venoms’ effects, but
these toxin genes are only a minute portion of the
genes expressed at high levels in the venom glands
(Figure 2). Rokyta et al. [17] found that for C. adaman-
teus, the nontoxin expression was heavily biased towards
genes involved in protein production and metabolism,
as expected for a tissue specialized for protein secre-
tion. Regardless of the particular proteins secreted, the
basic protein-secretory function of snake venom-glands
should be consistent across species, and we therefore
expected expression patterns among nontoxin sequences
to be more similar than patterns for toxins. To test
this hypothesis, we conducted a reciprocal-blast analy-
sis to identify orthologous sequences between the two
species and compared their expression levels. For a pair
of sequences to be included in our analysis, the two
sequences had to have been each other’s best blast hit
for both a nucleotide-based and an animo-acid-based
search with blastn and blastp, respectively. We excluded
mitochondrially encoded sequences for simplicity, leaving
2,870 nontoxins for C. adamanteus and 3,021 nontoxins
for C. horridus. From these sequences, we identified 1,903
reciprocal blast matches (Figure 8). For expression levels,
we used the number of reads mapping to each sequence
based on aligning 10 million reads from each species to
their own transcript sequences. Because the same num-
ber of reads were used for each species, this procedure is
effectively equivalent to using a percentage. If the overall
expression levels for nontoxins were similar between the
two species, which appeared to be the case (Figure 1), and
the expression levels of individual nontoxins were similar,
we would expect a linear relationship between expres-
sion values for the two species with a slope of one and
an intercept at zero. Instead, we found a good linear fit
(F1,1901 = 3.3 × 104, P  10−10, R2 = 0.95), but with
a slope of 0.48 and intercept of 417 reads when we used
C. horridus expression values as a response variable. This
lower-than-expected slope appeared to be caused by a sin-
gle major outlier point representing a protein disulfide
isomerase, the most highly expressed nontoxin identified
for both species. Removal of this single point gave a good
fit (F1,1900 = 1.4×104, P  10−10, R2 = 0.88) with a slope
of 0.95 and an intercept of 51, indicating that expression
levels for nontoxin sequences present for both species are
generally in close agreement.
Our reciprocal-blast analysis indicated fairly extensive
overlap between the nontoxins identified by means of
independent de novo transcriptome assemblies for each
species, but each species had ∼1,000 sequences without
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Mean nontoxin dN = 0.017









Figure 7 The distribution of pairwise nonsynonymous divergence (dN) for toxins compared to nontoxins showed an excess of outliers for
toxins. The histogram shows the null distribution of dN for pairs of nontoxin orthologs identified by means of a reciprocal blast search. The vertical
line denotes the cutoff for the 95th percentile for the nontoxins. The dN values for the toxins are plotted below the histogram, and those toxin
comparisons with values exceeding the 95th percentile for nontoxins are indictated with triangles and labeled with the names of the two
sequences compared. The P value is based on a Wilcoxon rank sum test and shows a significant difference in the mean dN between toxins and
nontoxins. Comparisons with dS > 0.1 were excluded, and those comparisons that also exceeded the synonymous divergence threshold (Figure 7)
are labeled with white triangles instead of grey. Excluding the dS outliers, we found that almost half of the toxin comparisons exceeded the
threshold established by the nontoxins, rather than the expected 5%.
reciprocal-blast hits. This difference could reflect a dif-
ference in the identities of particular genes expressed in
the two species’ venom-glands, which would represent a
substantial difference in expression patterns, or it could
simply represent a stochastic difference in the genes that
were successfully assembled and annotated. To determine
which of these two possibilities was true, we first filtered
readsmatching toxins for each species and then aligned 10
million of the filtered reads from each species against both
sets of annotated nontoxin sequences. For theC. adaman-
teus nontoxins, C. horridus reads mapped to all but four




























































Figure 8 Expression levels for nontoxins were conserved between Crotalus adamanteus and C. horridus despite major differences in
toxin-expression patterns. In all plots, the diagonal line indicates equal expression levels across species. (A) The comparison between species on
the basis of orthologs identified by means of a reciprocal-blast search. (B) The comparison between species on the basis of aligning 10 million reads
from each species against the nontoxin sequences from C. adamanteus. (C) The comparison between species on the basis of aligning 10 million
reads from each species against the nontoxin sequences from C. horridus. Note that for (B) and (C), the distortion in the pattern at lower read counts
is an artifact of the minimum-read-count threshold for annotating a contig.
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read). For the C. horridus nontoxins, C. adamanteus reads
mapped to all but a single nontoxin sequence (one more
had only a single mapped read). The estimated expression
levels in terms of number of mapped reads agreed well
between both species for both sets of nontoxins (Figure 8).
In addition, the total percentages of mapped reads were
similar for both species for both sets of nontoxins. For
the C. adamanteus transcripts, 42.6% and 41.2% of the
reads mapped for C. adamanteus and C. horridus, respec-
tively. For the C. horridus transcripts, 38.6% and 41.6%
of the reads mapped for C. adamanteus and C. horridus,
respectively. Note that in Figures 8A and 8B, read counts
when mapping a species’ reads against its own transcripts
showed a pattern of truncation on the lower end. This
truncation reflects our procedure for selecting transcripts
for annotation; we only tried to annotate contigs with at
least 200 reads for each round of assembly.
Gene expression patterns generally appear to be under
stabilizing selection [95-99], and the analyses above
showed that nontoxin expression patterns were conserved
across C. adamanteus and C. horridus despite major
changes in expression patterns for toxin genes. Thismakes
functional sense, because the same types of molecular
machinery are needed to serve the secretory function of
the venom-gland cells regardless of the particulars of the
proteins being expressed, but it does raise questions about
the regulatory control of gene expression in the venom
glands. Given the large number of genes involved for both
the toxins and nontoxins, and the relatively short diver-
gence time between these species, it seems likely that
toxins and nontoxins are under different regulatory con-
trol. This difference in control could contribute to the
evolvability of venom by allowing large-scale changes in
venom-gene expression without altering the underlying
machinery for toxin production.
Sequence accession numbers
The original, unmerged sequencing reads were submit-
ted to the National Center for Biotechnology Informa-
tion (NCBI) Sequence Read Archive under accession
number SRA058913. The assembled and annotated se-
quences were submitted to NCBI as a Transcriptome
Shotgun Assembly project. This Transcriptome Shotgun
Assembly project has been deposited at DDBJ/EMBL/
GenBank under the accession GAAZ00000000. The
version described in this paper is the first version,
GAAZ01000000.
Conclusions
Rattlesnakes rely on their venoms for feeding and defense,
and the ecological and evolutionary significance of these
venoms ensures variation in their properties and composi-
tions both within and between species. Themost dramatic
differences in rattlesnake venom properties correspond
to a long-recognized dichotomy between neurotoxic and
hemorrhagic venoms [29]. The timber rattlesnake (C. hor-
ridus) generally has hemorrhagic venom, but populations
along the southern edge of their range express highly
lethal, neurotoxic venom [44]. We sequenced the venom-
gland transcriptome of an individual from one of these
populations and compared the results to correspond-
ing data from the eastern diamondback rattlesnake (C.
adamanteus) [17], a congener with hemorrhagic venom.
The neurotoxic (type II) venom ofC. horriduswas about
half as complex in terms of number of expressed genes
as the hemorrhagic (type I) venom of C. adamanteus.
This simplicity of type II venommight explain the general
prevalence of type I venoms in rattlesnakes [29], despite
the apparent advantage in potency of type II venoms. The
higher complexity of type I venoms could provide evo-
lutionary advantages in terms of functional redundancy,
mutational robustness, and increased rates of adaptation
through an enlarged mutational target. The primary basis
for the lower complexity of the type II venom of C. hor-
ridus was the almost complete loss of expression of the
two major classes of diverse hemorrhagic toxins in type
I venoms, the CTLs and SVMPs. Overall, we found that
the drastic difference in venom properties resulted from
major changes in expression levels of toxin gene fami-
lies, differential gene-family expansion and loss, changes
in which paralogs within gene families were expressed at
high levels, and higher dN and dN/dS values in the toxin
genes relative to nontoxins. Despite the major expres-
sion differences for toxin transcripts, nontoxin expres-
sion patterns were consistent across the two species. Our
work represents the first high-throughput comparative
venom-gland transcriptomics study for snakes and there-
fore provides the first complete, in-depth look at patterns
of toxin gene-family evolution, molecular evolution, and
expression evolution in venomous snakes.
Methods
Venom-gland transcriptome sequencing
We followed the approach of Rokyta et al. [17] for the
preparation and sequencing of the venom gland. We
sequenced RNA from the venom glands of an adult female
C. horridus from Bradford County, Florida. The animal
weighed 1,134.7 g with a snout-to-vent length of 108 cm
and a total length of 116 cm. We stimulated transcription
in the glands by means of venom extraction under anes-
thesia [100]. The snake was anesthetized with a propofol
injection (10 mg/kg) and exposure to isoflurane gas, and
venom expulsion was initiated by means of electrostim-
ulation. After allowing four days for transcription to be
maximized [101], the animal was euthanized by injec-
tion of sodium pentobarbitol (100 mg/kg), and its venom
glands were removed and transferred into RNAlater. The
above techniques were approved by the Florida State
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University Institutional Animal Care and Use Committee
(IACUC) under protocol #0924.
Sequencing and nonnormalized cDNA library prepa-
ration were performed by the HudsonAlpha Institute
for Biotechnology Genomic Services Laboratory (http://
www.hudsonalpha.org/gsl/). Transcriptome sequencing
was performed essentially as described by Mortazavi et
al. [63] in a modification of the standard Illumina meth-
ods described in detail in Bentley et al. [102]. Total RNA
was reduced to poly-A+ RNA with oligo-dT beads. Two
rounds of poly-A+ selection were performed. The purified
mRNA was then subjected to a mild heat fragmentation
followed by random priming for first-strand synthesis.
Standard second-strand synthesis was followed by stan-
dard library preparation with the double-stranded cDNA
as input material. This approach is similar to that of Illu-
mina’s TruSeq RNA-seq library preparation kit. Sequenc-
ing was performed in one lane on the Illumina HiSeq 2000
with 100-base-pair paired-end reads.
Transcriptome assembly
We followed the iterative transcriptome assembly
approach of Rokyta et al. [17]. The majority of our read
pairs had overlapping 3’ ends, so we merged these pairs
into longer composite reads and updated their phred
quality scores accordingly [17,51]. We also checked for
and deleted any adapter sequences. Only these long,
high-quality merged reads were used for assembly. We
first eliminated extremely high-abundance transcripts by
running the Extender program as a de novo assembler on
a set of 1,000 random reads, as described by Rokyta et al.
[17]. Full-length coding sequences were identified with
blastx searches as described below. The resulting unique
sequences were used as templates in a reference-based
assembly with NGen3.1 with a 98% minimum match per-
centage. Ten million of the unassembled (i.e., unfiltered)
reads were used in a de novo transcriptome assembly with
NGen3.1 with the default settings for high-stringency,
de novo transcriptome assembly for long Illumina reads,
including default quality trimming. The high-stringency
setting corresponded to a minimum match percentage
of 93%, and we retained contigs comprising ≥200 reads.
Any resulting contigs with full-length coding sequences
were identified by means of blastx searches (see below).
We performed two more iterative rounds of this filter-
ing and de novo NGen assembly to yield the final set of
contigs. We checked for duplicates by assembling all of
the contigs with the SeqMan module of the DNAStar
Lasergene software suite. We had several levels of quality
control to prevent sequencing errors from being incorpo-
rated into our final sequences. We only used reads that
passed Illumina’s quality filter and that were merged into
overlapping, composite reads. All of our de novo assem-
blies with NGen used the default quality end trimming,
and we only retained contigs with substantial coverage
(≥200 reads).
We used blastx searches as implemented in mpiblast
version 1.6.0 (http://www.mpiblast.org/) for identifica-
tion and annotation of our contigs. Contig sequences
were searched against the NCBI nonredundant protein
database (nr) with an E-value cutoff of 10−4, and only the
best 10 matches were retained. For toxin identification,
hit descriptions were searched for a set of keywords based
on known snake-venom toxins and protein classes; any
sequence matching these keywords was checked for a full-
length putative-toxin encoding sequence. The remaining
contigs were screened for those whose match lengths
were ≥90% of the length of at least one of their database
matches. This step was intended to eliminate fragmented
or partial sequences before attempting annotation. Each
annotated sequence was checked and confirmed by hand
in the SeqBuilder module of the DNAStar Lasergene soft-
ware suite.
We estimated transcript abundances using high-
stringency reference-based assemblies in NGen3.1 with
a minimum match percentage of 95. Ten million of the
merged reads were mapped onto the full-length, anno-
tated transcripts, and the percentage of reads mapping
to each transcript was used as a proxy for abundance.
To compare nontoxin expression levels across species, we
aligned each species’ reads against both their own and
the other species’ annotated nontoxin transcripts using
reference-based assembly in NGen3.1 with a minimum
match percentage of 95. For each species, we used 10
million reads, after first filtering reads mapping to toxin
contigs.
Analysis of molecular-evolutionary patterns
Relationships among toxins within toxin families were
determined by means of maximum-likelihood phylogeny
estimation with PAUP*, version 4.0b10 [103] and the iter-
ative search strategy described by Rokyta et al. [104]. All
alignments were constructed with ClustalW [105]. Evo-
lutionary models were selected using MrModelTest ver-
sion 2 with Akaike Information Criterion values. Nodal
support was estimated by means of posterior clade prob-
abilities using MrBayes version 3.1.2 [106]. Markov chain
Monte Carlo searches were run for 10 million genera-
tions with four chains, the temperature parameter set to
0.2, and samples taken every 1,000 generations. Samples
from the first one million generations were discarded as
burn-in. To infer duplication and loss events on the esti-
mated phylogenies by reconciling them with the known
three-species phylogenies, we used Notung 2.6 [107,108].
To compare molecular-evolutionary patterns of tox-
ins to nontoxins, we identified orthologous pairs of
sequences from our two species by means of a reciprocal-
blast analysis. We constructed nucleotide and amino-acid
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sequence databases for each species, excluding mitochon-
drially encoded sequences, and blasted each sequence
from each species against the database generated for the
other species. We performed blastn and blastp searches
for each sequence with an E-value cutoff of 10−6. For
blastn searches, we used the entire sequence, includ-
ing untranslated regions. Putatively orthologous pairs
were only retained if the two constituent sequences were
each other’s best matches for both the nucleotide-based
and amino-acid-sequence-based analyses. The coding
sequences of retained pairs were aligned using ClustalW
[105]. Alignments with more than 24 gapped positions
in the coding sequences were excluded from further con-
sideration to avoid considering potentially incorrectly
annotated sequences. For the remaining orthologous
pairs, we estimated the pairwise synonymous (dS) and
nonsynonymous (dN) substitution rates and the pair-
wise ratios of nonsynonymous to synonymous substi-
tution rates (dN/dS) with codeml from PAML version
4.4 [109,110].
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